Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX and TME in Rectal Cancer
NCT00832299Phase 2Terminated
- Sponsor
- Mount Sinai Beth Israel
- Start
- Jan 2009
- Primary completion
- Aug 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, folinic acid, fluorouracil in rectal cancer, sponsored by Mount Sinai Beth Israel. Started Jan 2009; status: terminated.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00832299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832299.